From the "Emerging Growth" article linked earlier:
"On Sept 5th 2018 NTRP announced a collaboration with The Nemours/ Alfred I duPont Hospital for Children to conduct an open label pilot trial for Fragile X patients ages 8 – 18. This clinical trial is expected to commence testing soon."